Current issue
Online first
Archive
About the Journal
Editorial Office
Editorial Board
Publisher
Reviewers
Editorial policies
Ethical standards and procedures
Abstracting and indexing
Contact
Subscription
Instructions for authors
Article processing charge (APC)
English language editing services
Books and Events
Books
Events
REVIEW PAPER
Delivery and adjuvant: liposomes for SARS-CoV-2 vaccines
1
Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
2
Department of Biology, Faculty of Military Mathematics and Natural Sciences, Republic of Indonesia Defense University, Bogor, West Java, Indonesia
3
Immunology Research Center, National Health Research Institutes, Zhunan, Miaoli, Taiwan
Submission date: 2025-03-19
Final revision date: 2025-06-16
Acceptance date: 2025-06-28
Corresponding author
Indira Putri Negari
Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
KEYWORDS
TOPICS
ABSTRACT
The global COVID-19 pandemic has highlighted the critical role of vaccines in controlling infectious diseases, with liposome-based formulations emerging as a pivotal advancement in vaccine technology. Liposomes are spherical vesicles composed of lipid bilayers that serve as drug delivery systems and versatile adjuvants, enhancing vaccine efficacy through improved antigen stability, targeted delivery, and immunogenicity. This review explores the potential of liposomes as adjuvants in both mRNA and protein subunit SARS-CoV-2 vaccines, detailing their composition and dual impact on innate and adaptive immune responses. Notably, liposome-based mRNA vaccines, such as those developed by Pfizer and Moderna, have demonstrated high efficacy by utilizing lipid nanoparticles to encapsulate mRNA and stimulate antigen-presenting cells, thereby inducing robust immune responses. Despite their advantages, challenges remain, including the optimization of lipid compositions and the mitigation of adverse immune effects. This review also examines the broad applications of liposomes in nanomedicine — from cancer therapy to antifungal treatments — and their potential for future vaccine development. By bridging the gap between engineering and immunology, the study of liposomes underscores their transformative potential in addressing current and emerging global health challenges.
REFERENCES (157)
1.
Abhyankar MM, Mann BJ, Sturek JM, Brovero S, Moreau GB, Sengar A, Richardson CM, Agah S, Pomés A, Kasson PM, et al. 2021. Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant. NPJ Vaccines. 6(1): 137. https://doi.org/10.1038/s41541....
2.
Ahmadi Ashtiani HR, Bishe P, Lashgari NA, Nilforoushzadeh MA, Zare S. 2016. Liposomes in cosmetics. J Skin Stem Cell. 3(3). https://doi.org/10.5812/jssc.6....
3.
Ahmadpour ST, Mahéo K, Servais S, Brisson L, Dumas JF. 2020. Cardiolipin, the mitochondrial signature lipid: implication in cancer. Int J Mol Sci. 21(21): 1–16. https://doi.org/10.3390/ijms21....
4.
Alavi M, Hamidi M. 2019. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab Pers Ther. 34(1). https://doi.org/10.1515/dmpt-2....
5.
Alrbyawi H, Boddu SHS, Poudel I, Annaji M, Mita N, Arnold RD, Tiwari AK, Babu RJ. 2022. Cardiolipin for enhanced cellular uptake and cytotoxicity of thermosensitive liposome-encapsulated daunorubicin toward breast cancer cell lines. Int J Mol Sci. 23(19): 11763. https://doi.org/10.3390/ijms23....
6.
Alving CR, Beck Z, Matyas GR, Rao M. 2016. Liposomal adjuvants for human vaccines. Expert Opin Drug Deliv. 13(6): 807–816. https://doi.org/10.1517/174252....
7.
Ambati S, Ellis EC, Lin J, Lin X, Lewis ZA, Meagher RB. 2019. Dectin-2-targeted antifungal liposomes exhibit enhanced efficacy. MSphere. 4(5):e00715-19. https://doi.org/10.1128/mspher....
8.
Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK. 2022. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. BioNanoSci. 12(1): 274–291. https://doi.org/10.1007/s12668....
9.
Asadi K, Gholami A. 2021. Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: a review. Int J Biol Macromol. 182: 648–658. https://doi.org/10.1016/j.ijbi....
10.
Baserisalehi M. 2020. Preparation of liposomes from halophilic bacteria and their evaluation for drug delivery. Biomed J Sci Tech Res. 29(1). https://doi.org/10.26717/bjstr....
11.
Belfiore L, Saunders DN, Ranson M, Thurecht KJ, Storm G, Vine KL. 2018. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities. J Control Release. 277: 1–13. https://doi.org/10.1016/j.jcon....
12.
Bezerra CF, de Alencar Júnior JG, de Lima Honorato R, dos Santos ATL, Pereira da Silva JC, Gusmão da Silva T, Leal ALAB, Rocha JE, de Freitas TS, Tavares Vieira TA, et al. 2020. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole. Chem Phys Lipids. 233. https://doi.org/10.1016/j.chem....
13.
Bhattacharya I, Yadavalli T, Wu D, Shukla D. 2022. Plasma membrane-derived liposomes exhibit robust antiviral activity against HSV-1. Viruses. 14(4): 799. https://doi.org/10.3390/v14040....
14.
Bi Y, Xia H, Li L, Lee RJ, Xie J, Liu Z, Qiu Z, Teng L. 2019. Liposomal vitamin D3 as an anti-aging agent for the skin. Pharmaceutics. 11(7): 311. https://doi.org/10.3390/pharma....
15.
Blanken D, Foschepoth D, Serrão AC, Danelon C. 2020. Genetically controlled membrane synthesis in liposomes. Nat Commun. 11(1): 4317. https://doi.org/10.1038/s41467....
16.
Bochicchio S, Dalmoro A, De Simone V, Bertoncin P, Lamberti G, Barba AA. 2020. Simil-microfluidic nanotechnology in manufacturing of liposomes as hydrophobic antioxidants skin release systems. Cosmetics. 7(2): 22. https://doi.org/10.3390/COSMET....
17.
Boons GJ. 2010. Liposomes modified by carbohydrate ligands can target B cells for the treatment of B-cell lymphomas. Expert Rev Vaccines. 9(11): 1251–1256. https://doi.org/10.1586/erv.10....
18.
Bozzuto G, Molinari A. 2015. Liposomes as nanomedical devices. Int J Nanomedicine. 10: 975–999. https://doi.org/10.2147/IJN.S6....
19.
Briuglia ML, Rotella C, McFarlane A, Lamprou DA. 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 5(3): 231–242. https://doi.org/10.1007/s13346....
20.
Calzada E, Onguka O, Claypool SM. 2016. Phosphatidylethanolamine metabolism in health and disease. Int Rev Cell Mol Biol. 321: 29–88. https://doi.org/10.1016/bs.irc....
21.
Cerqueira NMFSA, Oliveira EF, Gesto DS, Santos-Martins D, Moreira C, Moorthy HN, Ramos MJ, Fernandes PA. 2016. Cholesterol biosynthesis: a mechanistic overview. Biochemistry. 55(39): 5483–5506. https://doi.org/10.1021/acs.bi....
22.
Chen J, Yao J, Ma Z, Peng P, Lu S, Hu Y, Xu F, Yang Y, Yang X. 2017. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition. J Liposome Res. 27(1): 21–31. https://doi.org/10.3109/089821....
23.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 9(6): 7204–7218. https://doi.org/10.18632/oncot....
24.
Chen ZJ, Yang SC, Liu XL, Gao Y, Dong X, Lai X, Zhu MH, Feng HY, Zhu X, Lu Q., et al. (2020) Nanobowl-supported liposomes improve drug loading and delivery. Nano Lett. 20(6): 4177–4187. https://doi.org/10.1021/acs.na....
25.
Chen Z, Liu F, Chen Y, Liu J, Wang X, Chen AT, Deng G, Zhang H, Liu J, Hong Z, et al. 2017. Targeted delivery of CRISPR/Cas9-mediated cancer gene therapy via liposome-templated hydrogel nanoparticles. Adv Funct Mater. 27(46): 1703036. https://doi.org/10.1002/adfm.2....
26.
Cheng CJ, Lu CY, Chang YH, Sun Y, Chu HJ, Lee CY, Liu CH, Lin CH, Lu CJ, Li CY. 2021. Effectiveness of the WHO-authorized COVID-19 vaccines: a rapid review of global reports till 30 June 2021. Vaccines. 9(12): 1489. https://doi.org/10.3390/vaccin....
27.
Cho EY, Ryu JY, Lee HAR, Hong SH, Park HS, Hong KS, Park SG, Kim HP, Yoon TJ. 2019. Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes. J Nanobiotechnol. 17(1): 19. https://doi.org/10.1186/s12951....
28.
Christensen D, Polacek C, Sheward DJ, Hanke L, Moliner-Morro A, McInerney G, Murrell B, Top Hartmann K, Elvang Jensen H, Jungersen G, et al. 2022. Protection against SARS-CoV-2 transmission by a parenteral prime-intranasal boost vaccine strategy. EBioMedicine. 84: 104248. https://doi.org/10.1016/j.
29.
Croci R, Bottaro E, Chan KWK, Watanabe S, Pezzullo M, Mastrangelo E, Nastruzzi C. 2016. Liposomal systems as nanocarriers for the antiviral agent ivermectin. Int J Biomater. 16: 8043983. https://doi.org/10.1155/2016/8....
30.
Crow MK, Olferiev M, Kirou KA. 2019. Type I interferons in autoimmune disease. Annu Rev Pathol. 13(4): 369-393. https://doi.org/10.1146/annure....
31.
Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44(1): 381–391. https://doi.org/10.3109/216914....
32.
De Carvalho CCCR, Caramujo MJ. 2018. The various roles of fatty acids. Molecules. 23(10): 2583. https://doi.org/10.3390/molecu....
33.
Dimov N, Kastner E, Hussain M, Perrie Y, Szita N. 2017. Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system. Sci Rep. 7(1): 12045. https://doi.org/10.1038/s41598....
34.
Doan LH, Chu LW, Huang ZY, Nguyen AT, Lee CY, Huang CL, Chang YF, Hsieh WY, Nguyen TTH, et al. 2022. Virofree, an herbal medicine-based formula, interrupts the viral infection of Delta and Omicron variants of SARS-CoV-2. Front Pharmacol. 13: 905197. https://doi.org/10.3389/fphar.....
35.
Du Y, He W, Xia Q, Zhou W, Yao C, Li X. 2019. Thioether phosphatidylcholine liposomes: a novel ROS-responsive platform for drug delivery. ACS Appl Mater Interfaces. 11(41): 37411–37420. https://doi.org/10.1021/acsami....
36.
Estanqueiro M, Conceição J, Amaral MH, Sousa Lobo JM. 2016. The role of liposomes and lipid nanoparticles in the skin hydration. Nanobiomater Galen Formul Cosmet. 10: 297–326. https://doi.org/10.1016/B978-0....
37.
Eusébio D, Neves AR, Costa D, Biswas S, Alves G, Cui Z, Sousa Â. 2021. Methods to improve the immunogenicity of plasmid DNA vaccines. Drug Discov Today. 26(11): 2575–2592. https://doi.org/10.1016/j.drud....
38.
Facciolà A, Visalli G, Laganà A, Di Pietro A. 2022. An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines. 10(5): 819. https://doi.org/10.3390/vaccin....
39.
Fan J, Jin S, Gilmartin L, Toth I, Hussein WM, Stephenson RJ. 2022. Advances in infectious disease vaccine adjuvants. Vaccines. 10(7): 1120. https://doi.org/10.3390/vaccin....
40.
Fan Y, Chen C, Huang Y, Zhang F, Lin G. 2017. Study of the pH-sensitive mechanism of tumor-targeting liposomes. Colloids Surf B. 151: 19–25. https://doi.org/10.1016/j.cols....
41.
Ferreira M, Ogren M, Dias JNR, Silva M, Gil S, Tavares L, Aires-Da-Silva F, Gaspar MM, Aguiar SI. 2021. Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules. 26(7): 2047. https://doi.org/10.3390/molecu....
42.
Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI. 2016. Antibacterial effects of liposomes containing phospholipid cardiolipin and fluoroquinolone levofloxacin on Mycobacterium tuberculosis with extensive drug resistance. Bull Exp Biol Med. 160(5): 675–678. https://doi.org/10.1007/s10517....
43.
Gao Y, Wijewardhana C, Mann JFS. 2018. Virus-like particle, liposome, and polymeric particle-based vaccines against HIV-1. Front Immunol. 9: 345. https://doi.org/10.3389/fimmu.....
44.
Gasanoff ES, Yaguzhinsky LS, Garab G. 2021. Cardiolipin, non-bilayer structures and mitochondrial bioenergetics: relevance to cardiovascular disease. Cells. 10(7): 1721. https://doi.org/10.3390/cells1....
45.
Gatto MS, Johnson MP, Najahi-Missaoui W. 2024. Targeted liposomal drug delivery: overview of the current applications and challenges. Life. 14(6): 672. https://doi.org/10.3390/life14....
46.
Gkionis L, Aojula H, Harris LK, Tirella A. 2021. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics. Int J Pharm. 604: 120711. https://doi.org/10.1016/j.ijph....
47.
Gonzalez Gomez A, Hosseinidoust Z. 2020. Liposomes for antibiotic encapsulation and delivery. ACS Infect Dis. 6(5): 896–908. https://doi.org/10.1021/acsinf....
48.
Gonzalez Gomez A, Syed S, Marshall K, Hosseinidoust Z. 2019. Liposomal nanovesicles for efficient encapsulation of staphylococcal antibiotics. ACS Omega. 4(6): 10866–10876. https://doi.org/10.1021/acsome....
49.
González-Rodríguez ML, Rabasco AM. 2011. Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin Drug Deliv. 8(7): 857–871. https://doi.org/10.1517/174252....
50.
Gregoriadis G. 2016. Liposomes in drug delivery: how it all happened. Pharmaceutics. 8(2): 19. https://doi.org/10.3390/pharma....
51.
Gregoriadis G. 2021. Liposomes and mRNA: two technologies together create a COVID-19 vaccine. Med Drug Discov. 12: 100104. https://doi.org/10.1016/j.medi....
52.
Haensler J. 2010. Liposomal adjuvants: preparation and formulation with antigens. Methods Mol Biol. 626: 73–90. https://doi.org/10.1007/978-1-....
53.
Hameed A, Fatima R, Malik K, Muqadas A, Fazal-Ur-Rehman M. 2019. Scope of nanotechnology in cosmetics: dermatology and skin care products. J Med Chem Sci. 2(2): 9–16. https://doi.org/10.26655/jmche....
54.
Henriksen-Lacey M, Korsholm KS, Andersen P, Perrie Y, Christensen D. 2011. Liposomal vaccine delivery systems. Expert Opin Drug Deliv. 8(4): 505–519. https://doi.org/10.1517/174252....
55.
Ho HM, Huang CY, Yang CH, Liu SJ, Chen HW, Yu GY, Chen JK, Chuang TH, Huang M.H. 2022. Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery. Pharmaceutics. 14(11): 2539. https://doi.org/10.3390/pharma....
56.
Hong HC, Kim KS, Park SA, Chun MJ, Hong EY, Chung SW, Kim HJ, Shin BG, Braka A, Thanappan J, et al. 2021. An mRNA vaccine against SARS-CoV-2: lyophilized, liposome-based vaccine candidate EG-COVID induces high levels of virus neutralizing antibodies. bioRxiv. https://doi.org/10.1101/2021.0....
57.
Hongtu Q, BoLi L, Jianguo C, Shusheng P, Ming M. 2023. Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice. Vaccine. 41(48): 7129–7137. https://doi.org/10.1016/j.vacc....
58.
Hou X, Zaks T, Langer R, Dong Y. 2021. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 6(12): 1078–1094. https://doi.org/10.1038/s41578....
59.
Huang Y, Anderson R. 2002. Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans. Vaccine. 20(11–12): 1586–1592. https://doi.org/10.1016/s0264-....
60.
Huang Z, Gong H, Sun Q, Yang J, Yan X, Xu F. 2024. Research progress on emulsion vaccine adjuvants. Heliyo. 10(3): e24662. https://doi.org/10.1016/j.heli....
61.
Ibaraki H, Kanazawa T, Oogi C, Takashima Y, Seta Y. 2019. Effects of surface charge and flexibility of liposomes on dermal drug delivery. J Drug Deliv Sci Technol. 50: 155–162. https://doi.org/10.1016/j.jdds....
62.
Iwasaki A, Medzhitov R. 2015. Control of adaptive immunity by the innate immune system. Nat Immunol. 16(4): 343–353. https://doi.org/10.1038/ni.312....
63.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, et al. 2020. An mRNA vaccine against SARS-CoV-2 – preliminary report. N Engl J Med. 383(20): 1920–1931. https://doi.org/10.1056/nejmoa....
64.
Ji YD, Harris JA, Gibson LE, McKinley SK, Phitayakorn R. 2021. The efficacy of liposomal bupivacaine for opioid and pain reduction: a systematic review of randomized clinical trials. J Surg Res. 264: 510–533. https://doi.org/10.1016/j.jss.....
65.
Jiang Y, Li W, Wang Z, Lu J. 2024. Lipid-based nanotechnology: liposome. Pharmaceutics. 16(1): 34. https://doi.org/10.3390/pharma....
66.
Joshi S, Bawage S, Tiwari P, Kirby D, Perrie Y, Dennis V, Singh SR. 2019. Liposomes: a promising carrier for respiratory syncytial virus therapeutics. Expert Opin Drug Deliv. 16(9): 969–980. https://doi.org/10.1080/174252....
67.
Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H. 2018. Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol. 113: 40–48. https://doi.org/10.1016/j.fct.....
68.
Keshari S, Shavkunov AS, Miao Q, Saha A, Minowa T, Mol-gora M, Williams CD, Chaib M, Highsmith AM, Pineda JE, et al. 2024. Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy. Cell Rep. 43(11): 114875. https://doi.org/10.1016/j.celr....
69.
Khoshnood S, Arshadi M, Akrami S, Koupaei M, Ghahramanpour H, Shariat A, Sadeghifard N, Heidary M. 2022. An overview on inactivated and live-attenuated SARS-CoV-2 vaccines. J Clin Lab Anal. 36(5): e24418. https://doi.org/10.1002/jcla.2....
70.
Kim EM, Jeong HJ. 2021. Liposomes: biomedical applications. Chonnam Med J. 57(1): 27. https://doi.org/10.4068/cmj.20....
71.
Kim H, Kim JT, Barua S, Yoo SY, Hong SC, Lee KB, Lee J. 2018. Seeking better topical delivery technologies of moisturizing agents for enhanced skin moisturization. Expert Opin Drug Deliv. 15(1): 17–31. https://doi.org/10.1080/174252....
72.
Kim H, Ro J, Barua S, Hwang DS, Na SJ, Lee HS, Jeong JH, Woo S, Kim H, Hong B, et al. 2015. Combined skin moisturization of liposomal serine incorporated in hydrogels prepared with Carbopol ETD 2020, Rhesperse RM 100 and hyaluronic acid. Korean J Physiol Pharmacol. 19(6): 543–547. https://doi.org/10.4196/kjpp.2....
73.
Korn T, Hiltensperger M. 2021. Role of IL-6 in the commitment of T cell subsets. Cytokine. 146: 155654. https://doi.org/10.1016/j.cyto....
74.
Kozhikhova KV, Ivantsova MN, Tokareva MI, Shulepov ID, Tretiyakov AV, Shaidarov LV, Rusinov VL, Mironov MA. 2018. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin. Pharm Dev Technol. 23(4): 334–342. https://doi.org/10.1080/108374....
75.
Kraft JC, Freeling JP, Wang Z, Ho RJY. 2014. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci. 103(1): 29–52. https://doi.org/10.1002/jps.23....
76.
Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H, et al. 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 534(7607): 396–401. https://doi.org/10.1038/nature....
77.
Krasnopolsky Y, Pylypenko D. 2022. Licensed liposomal vaccines and adjuvants in the antigen delivery system. Biotechnologia. 103(4): 409–423. https://doi.org/10.5114/bta.20....
78.
Lamichhane N, Udayakumar TS, D’Souza WD, Simone CB, Raghavan SR, Polf J, Mahmood J. 2018. Liposomes: clinical applications and potential for image-guided drug delivery. Molecules. 23(2): 288. https://doi.org/10.3390/molecu....
79.
Leaman DP, Stano A, Chen Y, Zhang L, Zwick MB. 2021. Membrane Env liposomes facilitate immunization with multivalent full-length HIV spikes. J Virol. 95(13): e0000521. https://doi.org/10.1128/jvi.00....
80.
Lee Y, Jeong M, Park J, Jung H, Lee H. 2023. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp Mol Med. 55(10): 2085–2096. https://doi.org/10.1038/s12276....
81.
Li B, Jones LL, Geiger TL. 2018. IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level RORgt expression. J Immunol. 201(10): 2934–2946. https://doi.org/10.4049/jimmun....
82.
Li J, Gray BD, Pak KY, Ng CK. 2019. Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer. Nucl Med Biol. 78–79: 23–30. https://doi.org/10.1016/j.nucm....
83.
Lim EB, Haam S, Lee SW. 2021. Sphingomyelin-based liposomes with different cholesterol contents and polydopamine coating as a controlled delivery system. Colloids Surf A Physicochem Eng Asp. 618: 126447. https://doi.org/10.1016/j.cols....
84.
Liu C, Zhang L, Zhu W, Guo R, Sun H, Chen X, Deng N. 2020. Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther Methods Clin Dev. 18: 751–764. https://doi.org/10.1016/j.omtm....
85.
Liu P, Chen G, Zhang J. 2022. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 27(4): 1372. https://doi.org/10.3390/molecu....
86.
Lombardo D, Kiselev MA, Caccamo MT. 2019. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. https://doi.org/10.1155/2019/3....
87.
Lovell JF, Miura K, Baik YO, Lee C, Lee JY, Park YS, Hong I, Lee JH, Kim T, Seo SH, et al. 2024. One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects. Int J Infect Dis. 138: 73–80. https://doi.org/10.1016/j.ijid....
88.
Mabrouk MT, Chiem K, Rujas E, Huang WC, Jahagirdar D, Quinn B, Surendran Nair M, Nissly RH, Cavener VS, Boyle NR, et al. 2021. Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice. Sci Adv. 7(49). https://doi.org/10.1126/sciadv....
89.
Majzoub RN, Ewert KK, Safinya CR. 2016. Cationic liposome-nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing. Philos Trans R Soc A. 374(2072): 20150129. https://doi.org/10.1098/rsta.2....
90.
Mennini N, Mura P, Nativi C, Richichi B, Di Cesare Mannelli L, Ghelardini C. 2015. Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management. Future Sci OA. 1(3): FSO2. https://doi.org/10.4155/fso.14....
91.
Milicic A, Kaur R, Reyes-Sandoval A, Tang CK, Honeycutt J, Perrie Y, Hill AVS. 2012. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. PLoS One. 7(3): e34255. https://doi.org/10.1371/journa....
92.
Mohamed M, Abu Lila AS, Shimizu T, Alaaeldin E, Hussein A, Sarhan HA, Szebeni J, Ishida T. 2019. PEGylated liposomes: immunological responses. Sci Technol Adv Mater. 20(1): 710–724. https://doi.org/10.1080/146869....
93.
Mohan T, Verma P, Rao DN. 2013. Novel adjuvants and delivery vehicles for vaccines development: a road ahead. Indian J Med Res. 138: 779–795.
94.
Mojarad-Jabali S, Farshbaf M, Walker PR, Hemmati S, Fatahi Y, Zakeri-Milani P, Sarfraz M, Valizadeh H. 2021. An update on actively targeted liposomes in advanced drug delivery to glioma. Int J Pharm. 602: 120645. https://doi.org/10.1016/j.ijph....
95.
Mukherjee A, Bisht B, Dutta S, Paul MK. 2022. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy. Acta Pharmacol Sin. 43(11): 2759–2776. https://doi.org/10.1038/s41401....
96.
Musielak E, Krajka V, KuŸniak K. 2024. Liposomes and ethosomes: comparative potential in enhancing skin permeability for therapeutic and cosmetic applications. Cosmetics. 11(6): 191. https://doi.org/10.3390/cosmet....
97.
Narayanan DKL, Djearamane S, Fuloria S, Kayarohanam S, Subramaniyan V, Sekar M, Fuloria NK. 2022. A review on DNA vaccines in pre-clinical trials against SARS-CoV-2. J Exp Biol Agric Sci. 10(3): 487–493. https://doi.org/10.18006/2022.....
98.
Ndwandwe D, Wiysonge CS. 2021. COVID-19 vaccines. Curr Opin Immunol. 71: 111–116. https://doi.org/10.1016/j.coi.....
99.
Neves LF, Duan J, Voelker A, Khanal A, McNally L, Steinbach-Rankins J, Ceresa BP. 2016. Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells. J Microencapsul. 33(4): 391–399. https://doi.org/10.1080/026520....
100.
Newton K, Dixit VM. 2012. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 4(3): a006049. https://doi.org/10.1101/cshper....
101.
Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. 2014. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol. 32(1): 32–45. https://doi.org/10.1016/j.tibt....
102.
Nordly P, Madsen HB, Nielsen HM, Foged C. 2009. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv. 6(7): 657–672. https://doi.org/10.1517/174252....
103.
Nosova AS, Koloskova OO, Nikonova AA, Simonova VA, Smirnov VV, Kudlay D, Khaitov MR. 2019. Diversity of PEGylation methods of liposomes and their influence on RNA delivery. MedChemComm. 10(3): 369–377. https://doi.org/10.1039/c8md00....
104.
Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. 2022. Liposomes: structure, composition, types, and clinical applications. Heliyon. 8(5): e09394. https://doi.org/10.1016/j.heli....
105.
Ober Shepherd BL, Scott PT, Hutter JN, Lee C, McCauley MD, Guzman I, Bryant C, McGuire S, Kennedy J, Chen WH, et al. 2024. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial. Lancet Microbe. 5(6): e581–e593. https://doi.org/10.1016/S2666-...) 00410-X.
106.
Ochoa-Sánchez C, Rodríguez-León E, Iñiguez-Palomares R, Rodríguez-Beas C. 2024. Brief comparison of the efficacy of cationic and anionic liposomes as nonviral delivery systems. ACS Omega. 9(47): 46664–46678. https://doi.org/10.1021/acsome....
107.
Orosco FL, Espiritu LM. 2024. Navigating the landscape of adjuvants for subunit vaccines: recent advances and future perspectives. Int J Appl Pharm. 16(1): 18–32. https://doi.org/10.22159/ijap.....
108.
Pasarin D, Ghizdareanu AI, Enascuta CE, Matei CB, Bilbie C, Paraschiv-Palada L, Veres PA. 2023. Coating materials to increase the stability of liposomes. Polymers. 15(3): 782. https://doi.org/10.3390/polym1....
109.
Pattni BS, Chupin VV, Torchilin VP. 2015. New developments in liposomal drug delivery. Chem Rev. 115(19): 10938–10966. https://doi.org/10.1021/acs.ch....
110.
Pavlou P, Siamidi A, Varvaresou A, Vlachou M. 2021. Skin care formulations and lipid carriers as skin moisturizing agents. Cosmetics. 8(3): 89. https://doi.org/10.3390/cosmet....
111.
Pérez-Herrero E, Fernández-Medarde A. 2015. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 93: 52–79. https://doi.org/10.1016/j.ejpb....
112.
Perrie Y. 2008. Introducing liposomes to drug delivery. J Drug Target. 16(7–8): 518–519. https://doi.org/10.1080/ 10611860802228376.
113.
Perrie Y, Kastner E, Khadke S, Roces CB, Stone P. 2017. Manufacturing methods for liposome adjuvants. Methods Mol Biol. 1494: 127–144. https://doi.org/10.1007/978-1-....
114.
Pinilla CMB, Thys RCS, Brandelli A. 2019. Antifungal properties of phosphatidylcholine-oleic acid liposomes encapsulating garlic against environmental fungal in wheat bread. Int J Food Microbiol. 293: 72–78. https://doi.org/10.1016/j.ijfo....
115.
Ponti F, Campolungo M, Melchiori C, Bono N, Candiani G. 2021. Cationic lipids for gene delivery: many players, one goal. Chem Phys Lipids. 235: 105032. https://doi.org/10.1016/j.chem....
116.
Poon C, Patel AA. 2020. Organic and inorganic nanoparticle vaccines for prevention of infectious diseases. Nano Express. 1(1). https://doi.org/10.1088/2632-9....
117.
Pulendran B, Arunachalam PS, O’Hagan DT. 2021. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 20(6): 454–475. https://doi.org/10.1038/s41573....
118.
Ren H, He Y, Liang J, Cheng Z, Zhang M, Zhu Y, Hong C, Qin J, Xu X, Wang J. 2019. Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy. ACS Appl Mater Interfaces. 11(22): 20304–20315. https://doi.org/10.1021/acsami....
119.
Riaz MK, Riaz MA, Zhang X, Lin C, Wong KH, Chen X, Zhang G, Lu A, Yang Z. 2018. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci. 19(1): 195. https://doi.org/10.3390/ijms19....
120.
Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, Wood RA, Milner JD. 2021. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol. 147(6): 2075–2082.e2. https://doi.org/10.1016/j.jaci....
121.
Rodà F, Picciolini S, Mangolini V, Gualerzi A, Seneci P, Renda A, Sesana S, Re F, Bedoni M. 2023. Raman spectroscopy characterization of multi-functionalized liposomes as drug-delivery systems for neurological disorders. Nanomaterials. 13(4): 699. https://doi.org/10.3390/nano13....
122.
dos Santos Rodrigues B, Oue H, Banerjee A, Kanekiyo T, Singh J. 2018. Dual functionalized liposome-mediated gene delivery across triple co-culture blood-brain barrier model and specific in vivo neuronal transfection. J Control Release. 286: 264–278. https://doi.org/10.1016/j.jcon....
123.
Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. 2021. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 601. https://doi.org/10.1016/j.ijph....
124.
Serrano G, Almudéver P, Serrano JM, Milara J, Torrens A, Expósito I, Cortijo J. 2015. Phosphatidylcholine liposomes as carriers to improve topical ascorbic acid treatment of skin disorders. Clin Cosmet Investig Dermatol. 8: 591–599. https://doi.org/10.2147/CCID.S....
125.
Sharma VK, Agrawal MK. 2021. A historical perspective of liposomes – a bio-nanomaterial. Mater Today Proc. 45: 2963–2966. https://doi.org/10.1016/j.matp....
126.
Shen Z, Fisher A, Liu WK, Li Y. 2018. PEGylated “stealth” nanoparticles and liposomes. Eng Biomater Drug Deliv Syst. 1–26. https://doi.org/10.1016/B978-0....
127.
Shen Z, Ye C, McCain K, Greenberg ML. 2015. The role of cardiolipin in cardiovascular health. Biomed Res Int. https://doi.org/10.1155/2015/8....
128.
Shi D, Mi G, Shen Y, Webster TJ. 2019. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier. Nanoscale. 11(32): 15057–15071. https://doi.org/10.1039/c9nr03....
129.
Silveira MM, Moreira GMSG, Mendonça M. 2021. DNA vaccines against COVID-19: perspectives and challenges. Life Sci. 267: 118919. https://doi.org/10.1016/j.lfs.....
130.
Snyder MA, Scheuerman CM, Gregg JL, Ruhnke CJ, Eten K. 2016. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension. Arthroplasty Today. 2(1): 37–42. https://doi.org/10.1016/j.artd....
131.
Song H, Wang G, He B, Li L, Li C, Lai Y, Xu X, Gu Z. 2012. Cationic lipid-coated PEI/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells. Int J Nanomedicine. 7: 4637–4648. https://doi.org/10.2147/IJN.S3....
132.
Soni V, Chandel S, Jain P, Asati S. 2016. Role of liposomal drug-delivery system in cosmetics. Nanobiomater. Galenic Formul Cosmet. 93–108. https://doi.org/10.1016/B978-0....
133.
Sporer SM, Rogers T. 2016. Postoperative pain management after primary total knee arthroplasty: the value of liposomal bupivacaine. J Arthroplasty. 31(11): 2603–2607. https://doi.org/10.1016/j.arth....
134.
Tada R, Hidaka A, Iwase N, Takahashi S, Yamakita Y, Iwata T, Muto S, Sato E, Takayama N, Honjo E, et al. 2015. Intranasal immunization with dotap cationic liposomes combined with DC-cholesterol induces potent antigen-specific mucosal and systemic immune responses in mice. PLoS One. 10(10): e0139785. https://doi.org/10.1371/journa....
135.
Tahtinen S, Tong AJ, Himmels P, Oh J, Paler-Martinez A, Kim L, Wichner S, Oei Y, McCarron MJ, Freund EC, et al. 2022. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 23(4): 532–542. https://doi.org/10.1038/s41590....
136.
Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell. 140(6): 805–820. https://doi.org/10.1016/j.cell....
137.
Tretiakova DS, Vodovozova EL. 2022. Liposomes as adjuvants and vaccine delivery systems. Biochemistry (Moscow) Suppl Ser A Membr Cell Biol. 16(1): 1–20. https://doi.org/10.1134/S19907....
138.
Tseu GYW, Kamaruzaman KA. 2023. A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer. Molecules. 28(3): 1498. https://doi.org/10.3390/molecu....
139.
Tyagi P, Kashyap M, Majima T, Kawamorita N, Yoshizawa T, Yoshimura N. 2017. Intravesical liposome therapy for interstitial cystitis. Int J Urol. 24(4): 262–271. https://doi.org/10.1111/iju.13....
140.
Vera-Gonzále N, Bailey-Hytholt CM, Langlois L, de Camargo Ribeiro F, de Souza Santos EL, Junqueira JC, Shukla A. 2020. Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans. J Biomed Mater Res A. 108(11): 2263–2276. https://doi.org/10.1002/jbm.a.....
141.
Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M. 2018. Understanding modern-day vaccines: what you need to know. Ann Med. 50(2): 110–120. https://doi.org/10.1080/078538....
142.
Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, et al. 2022. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 603(7902): 679–686. https://doi.org/10.1038/s41586....
143.
Vovesná A, Zhigunov A, Balouch M, Zbytovská J. 2021. Ceramide liposomes for skin barrier recovery: a novel formulation based on natural skin lipids. Int J Pharm. 596: 120264. https://doi.org/10.1016/j.ijph....
144.
Wang S, Chen Y, Guo J, Huang Q. 2023. Liposomes for tumor targeted therapy: a review. Int J Mol Sci. 24(3): 2643. https://doi.org/10.3390/ijms24....
145.
Wang Z, Li W, Jiang Y, Park J, Gonzalez KM, Wu X, Zhang QY, Lu J. 2024. Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nat Commun. 15(1): 2073. https://doi.org/10.1038/s41467....
146.
Xing H, Hwang K, Lu Y. 2016. Recent developments of liposomes as nanocarriers for theranostic applications. Theranostics. 6(9): 1336–1352. https://doi.org/10.7150/thno.1....
147.
Yan W, Huang L. 2007. Recent advances in liposome-based nanoparticles for antigen delivery. Polym Rev. 47(3): 329–344. https://doi.org/10.1080/155837....
148.
Yanasarn N, Sloat BR, Cui Z. 2011. Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Mol Pharm. 8(4): 1174–1185. https://doi.org/10.1021/mp2000....
149.
Yang JX, Tseng JC, Tien CF, Lee CY, Liu YL, Lin JJ, Tsai PJ, Liao HC, Liu SJ, Su YW, et al. 2023. TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses. Int J Biol Sci. 19(9): 2897–2913. https://doi.org/10.7150/ijbs.8....
150.
Zamani P, Momtazi-Borojeni AA, Nik ME, Oskuee RK, Sahebkar A. 2018. Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy. J Cell Physiol. 233(7): 5189–5199. https://doi.org/10.1002/jcp.26....
151.
Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. 2023. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 8(1): 283. https://doi.org/10.1038/s41392....
152.
Zhen S, Li X. 2020. Liposomal delivery of CRISPR/Cas9. Cancer Gene Ther. 27(7–8): 515–527. https://doi.org/10.1038/s41417....
153.
Zhen S, Takahashi Y, Narita S, Yang YC, Li X. 2017. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome. Oncotarget. 8(6): 9375-9387. https://doi.org/10.18632/oncot....
154.
Zhou S, Luo Y, Lovell JF. 2023. Vaccine approaches for antigen capture by liposomes. Expert Rev Vaccines. 22(1): 1022–1040. https://doi.org/10.1080/147605....
155.
Zhu H, Chen HJ, Wen HY, Wang ZG, Liu SL. 2023. Engineered lipidic nanomaterials inspired by sphingomyelin metabolism for cancer therapy. Molecules. 28(14): 5366. https://doi.org/10.3390/molecu....
156.
Zununi Vahed S, Salehi R, Davaran S, Sharifi S. 2017. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C. 71: 1327–1341. https://doi.org/10.1016/j.msec....
157.
Zylberberg C, Gaskill K, Pasley S, Matosevic S. 2017. Engineering liposomal nanoparticles for targeted gene therapy. Gene Ther. 24(8): 441–452. https://doi.org/10.1038/gt.201....
Share
RELATED ARTICLE
| eISSN: | 2353-9461 |
| ISSN: | 0860-7796 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
